Iradj Maany
Addiction Medicine · Phila, PANPI 1912005794
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 66 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by AbbVie at 27.0% of the total. Reporting peaked in 2019 at $1,732 and has fallen 86.7% since, to $231 in 2024.
Across 66 payments — averaging $38.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$694
- Otsuka America Pharmaceutical, Inc.$491
- Johnson & Johnson$286
- Takeda Pharmaceuticals U.S.A., Inc.$164
- Lundbeck LLC$150
- Sunovion Pharmaceuticals Inc.$147
- plus $639 from 9 others
What the payments were for
- Food & beverage$2,571100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 7 | $694 |
| Otsuka America Pharmaceutical, Inc. | 12 | $491 |
| Johnson & Johnson | 7 | $286 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $164 |
| Lundbeck LLC | 7 | $150 |
| Sunovion Pharmaceuticals Inc. | 3 | $147 |
| Teva Pharmaceuticals USA, Inc. | 4 | $128 |
| Axsome Therapeutics, Inc. | 1 | $120 |
| Neos Therapeutics, LP | 4 | $92 |
| Shire North American Group Inc | 5 | $88 |
| Neurocrine Biosciences, Inc. | 2 | $67 |
| Adlon Therapeutics L.p. | 3 | $52 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $50 |
| Jazz Pharmaceuticals Inc. | 1 | $25 |
| Neuronetics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,571 in reported general payments places this provider in the 80th percentile of 82 addiction medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 30 | $4,451 |
| Clozapine | 12 | $959 |
| Buspirone Hcl | 34 | $943 |
| Lorazepam | 57 | $744 |
| Alprazolam | 87 | $592 |
| Bupropion XlBupropion Hcl | 30 | $516 |
| Divalproex Sodium | 17 | $441 |
| Escitalopram Oxalate | 24 | $432 |
| Oxcarbazepine | 23 | $428 |
| Trazodone Hcl | 69 | $408 |
| Duloxetine Hcl | 42 | $400 |
| Estazolam | 16 | $374 |
| Fluoxetine Hcl | 49 | $300 |
| Divalproex Sodium ErDivalproex Sodium | 14 | $299 |
| Gabapentin | 18 | $290 |
Paid to pharmacies, not to this prescriber.
Other addiction medicine in Phila
- Karen SeesKane$928K
- Christopher DavisYork$226K
- William SantoroWest Reading$93K
- Philip MooreLemoyne$6K
- Carol LudolphHuntingdon Valley$5K
- Henry LuuWest Chester$5K
- Bernard HarrisNewtown Square$4K
- Jacques ChellyPittsburgh$4K
- Michael Halldu Bois$4K
- Adam ScioliWernersville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.